ArticleWorld journal of gastroenterology2017

Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation.

Hsi-Hsien Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.